GLUE – monte rosa therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) institutional investors lost 12% last week but have benefitted from longer-term gains [Yahoo! Finance]
Monte Rosa Therapeutics (NASDAQ:GLUE) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Monte Rosa Therapeutics (NASDAQ:GLUE) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Form 144 Monte Rosa Therapeutics, Filed by: Janku Filip
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BAKER BROS. ADVISORS LP
Form S-3ASR Monte Rosa Therapeutics,
Form 8-K Monte Rosa Therapeutics, For: Feb 09
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.